A New Way To Stay Well: Alomune Launches In The US
NEW YORK, Oct. 1, 2012 /PRNewswire/ -- Lonza, a global leader in the life sciences industry, is pleased to announce the launch of Alomune, a safe, daily immune supplement made with natural extracts from the renewable Minnesota Larch Tree that optimize the body's immune response to help people stay healthy.
"We are extremely pleased to introduce Alomune to the market," said Marshall Fong, Director of Consumer Marketing for Lonza. "Unlike many other immune products currently available to consumers, Alomune is meant to be taken daily, when you do feel well. Consumers tell us that they are extremely interested in trying products like Alomune and would prefer them over the types of immune products you often find in stores today that are designed to be taken when you don't feel well."
The main ingredient in Alomune, larch arabinogalactan, is an immune-enhancing, plant-based carbohydrate that is extracted from larch trees, also known as Tamarack. Larch arabinogalactan counts toward daily fiber intake and has antioxidant activity, as measured by Oxygen Radical Absorbance Capacity (ORAC) per 100 grams, similar to that of pomegranates. It is taken from densely populated larch trees in Minnesota under good state forestry management practices.
"Alomune is a vital addition to the wellness market that highlights the idea of maintaining the immune system to achieve good health," said Dr. Dan Johnston, military public health expert and Alomune spokesperson. "It's important to be as resilient as possible to immune challenges, and Alomune helps optimize the body's natural defenses, keeping it strong and protected."One of the very few dietary supplements backed by the Good Housekeeping Seal, Alomune was tested in a 12-week, double-blind, placebo-controlled clinical trial on over 200 healthy adults that suggested that those who took Alomune daily had twice the odds of staying healthy on measured health outcomes versus those taking placebo. Among participants, 57% more stayed healthy taking Alomune versus the placebo.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV